Dennis Patrick Molnar
President & COOMr. Dennis Patrick Molnar, M.B.A., serves as Chief Operating Officer of Apnimed, Inc. from August 2018 and serves as its President since March 2024 and also served as its Director. Mr. Molnar served as the Chief Executive Officer of President of Paratek Pharmaceuticals, Inc. from February 2012 to July 1, 2014 and served as its Vice President of Corporate Development. Mr. Molnar has ten years of experience in the pharmaceutical and biotechnology industries, working in a variety of capacities, including business development, management, finance and consulting. Mr. Molnar served as President of JBI Associates LLC. From 1998 to 2000, Mr. Molnar served as Director of Finance and Business Development at Magainin Pharmaceuticals. Mr. Molnar has held a series of positions at Bogart Delafield Ferrier Inc. He served as a Director of Paratek Pharmaceuticals, Inc. since February 2012. He served as a Director of NovaDx Ventures Corp. from October 15, 2010 to October 2011. Mr. Molnar has an MBA in Healthcare Management from the Wharton School of Management in 1998. He holds an Engineering degree from UBC and MBA from University of Western Ontario. He holds a BA in Economics and Biology from Brown University.
Positions
- Company NameApnimed, Inc.Stock CodeAPMDPositionPresident & COOColleagues
- KRKevin Robert LindCEO & Director
- PJPaul J. SekhriIndependent Chair of the Board
- LGLawrence G. MillerFounder & Vice Chair of the Board
- LTLuigi Taranto MontemurroCo-Founder & Chief Scientific Officer
- MBMichael B. KellyChief Financial Officer
- PRPaul R. FonteyneIndependent Director
- GLGary L. SenderIndependent Director
